Results 51 to 60 of about 5,525 (123)

The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo

Drug Design, Development and Therapy, 2018
Dmitrij A Sychev,1 Ghulam Md Ashraf,2 Andrey A Svistunov,3 Maksim L Maksimov,4 Vadim V Tarasov,3 Vladimir N Chubarev,3 Vitalij A Otdelenov,1 Natal’ja P Denisenko,1 George E Barreto,5,6 Gjumrakch Aliev7–9 1Russian Medical Academy of ...
Sychev DA, Ashraf GM, Svistunov AA, Maksimov ML, Tarasov VV, Chubarev VN, Otdelenov VA, Denisenko NP, Barreto GE, Aliev G   +9 more
doaj  

Effects of Celecoxib and Etoricoxib on the Pharmacokinetics and Pharmacological Effects of Orally Administered Tramadol: A Randomised Controlled Trial. [PDF]

Basic Clin Pharmacol Toxicol
Saarikoski T, Saari TI, Backman JT, Niemi M, Neuvonen PJ, Olkkola KT, Laine K.   +6 more
europepmc   +1 more source

Evaluation of the cytochrome P450-mediated drug interaction profile of olorofim. [PDF]

Antimicrob Agents Chemother
Cornelissen K, Rex JH, Zinzi D, Law D, Upcott Gill R, Jones HM, Maertens J, Chen SC-A, Brüggemann R.   +8 more
europepmc   +1 more source

Associations of CYP2B6, CYP2C19, and CYP2D6 isoforms and phenoconversion with sertraline pharmacokinetics. [PDF]

PLoS One
Tapia-Alzuguren B, Canga-Espina C, Molero P, Aldaz A.   +3 more
europepmc   +1 more source

Effect of Individual and Combined Cytochrome P450 Activity Scores on Symptom Improvement and Side Effects in Youth Treated With Sertraline. [PDF]

Clin Transl Sci
Gerlach S, Maruf AA, Shaheen SM, McCloud R, Heintz M, McAusland L, Arnold PD, Bousman CA.   +7 more
europepmc   +1 more source

Cardiovascular prescriber attitudes to pharmacogenomics: a survey by the ESC working group on cardiovascular pharmacotherapy. [PDF]

Pharmacogenomics J
Magavern EF, Dan GA, Savarese G, Borghi C, Dobrev D, Tamargo J, Ferdinandy P, McDermott JH, Newman WG, Pirmohamed M, Caulfield MJ, Kaski JC.   +11 more
europepmc   +1 more source

Integrating Genetic Variants and Expression Profiles of Pharmacogenes to Investigate Resistance to Antidepressant Treatment. [PDF]

Medicina (Kaunas)
Pisanu C, Squassina A, Perera-Bel J, Silva RC, Buson L, Sires AM, Bortolomasi M, Menesello V, Perusi G, Carpiniello B, Ferensztajn-Rochowiak E, Rybakowski F, Sanz F, Manchia M, Potier MC, Dierssen M, Prompt Study Group, Baune BT, Gennarelli M, Minelli A.   +19 more
europepmc   +1 more source

Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing population. [PDF]

Pharmacogenomics J
Baye JF, Petry NJ, Hines L, Weaver M, Reinke M, Brady H, Massmann A, Schultz A.   +7 more
europepmc   +1 more source

Cross-species metabolic characterization of eutylone and mechanism-based inhibition of CYP2D6 and CYP2B6 with drug interaction implications. [PDF]

Sci Rep
Lee MS, Song IS, Jang Y, Cho YY, Lee JY, Kang HC, Kim JH, Lee HS.   +7 more
europepmc   +1 more source

CYP2E1 and CYP2D6 in Anti-Tuberculosis Drug-Induced Liver Injury: Mechanisms, Epigenetic Regulation, and Translational Implications. [PDF]

Clin Transl Sci
Prakongsup P, Udomsinprasert W.
europepmc   +1 more source